CIRM Leads National Effort to Forge 'Pathways' with FDA
California's $3 billion stem cell agency has created a broad-based, 43-member, interstate consortium of researchers and businesses to work with the FDA to develop “well-defined regulatory pathways for stem cell therapies.”
CIRM President Alan Trounson is high on the effort, which will be making another quasi-public appearance in just a few days. Last spr…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.